drugset / Trial / NCT01851759
Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction
RandomizedParallel-groupDouble-blindTreatment
Summary
Using placebo as control, The purpose of this study is to evaluate the efficacy and safety of methanesulfonic acid cinepazide injection to relieve disabled degree of acute cerebral infarction patients, and explore the best safe and effective dose as well as dose method.
Timeline
- Start
- 2013-10
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cinepazide | Small molecule | 125 mg | Intravenous |